PMID- 7705946 OWN - NLM STAT- MEDLINE DCOM- 19950510 LR - 20190708 IS - 0020-7136 (Print) IS - 0020-7136 (Linking) VI - 61 IP - 2 DP - 1995 Apr 10 TI - Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses. PG - 185-91 AB - Chromosome I abnormalities are indicators of prognosis in neuroblastoma (NB) but are not yet routinely exploited because conventional methods are technically demanding. We evaluated the pertinence of interphase cytogenetics fluorescence in situ hybridization (FISH) for the analysis of chromosome I in NB, compared with conventional methods. Deletion of Ip was detected in 8 of 9 cell lines analyzed by both FISH and restriction fragment length polymorphism (RFLP), but was evidenced in only 2 cases by conventional cytogenetics, painting analysis being required to reveal the other cases. The chromosome I number evaluated by FISH reflected the total chromosome modal number obtained by cytogenetics. Twenty-eight specimens obtained from ultrasound-guided punctures, surgical biopsies of the primary tumor and bone-marrow aspirates were studied by FISH on frozen cytocentrifuged smears; 12 had a chromosome I trisomy and 16 a disomy. Requirements for a reliable control analysis of Ip deletion by RFLP were met in only 23 cases. The retention of 2 alleles was observed in 15 cases and Ip deletion in 7, by both techniques. In one case, an interstitial deletion of Ip was evidenced only by RFLP, and one of 5 cases analyzed only by FISH had a Ip deletion. Although FISH might be improved by using additional probes, it presents major advantages for routine exploitation. Determining Ip deletion in individual cells makes it possible to analyze small and heterogeneous tumoral specimens; the technique requires only a few hours and can easily be standardized in non-specialized laboratories. The number of chromosome I homologues per cell might serve as a rapid screening for ploidy. FAU - Combaret, V AU - Combaret V AD - Department of Radiology, Centre Leon Berard, Lyon, France. FAU - Turc-Carel, C AU - Turc-Carel C FAU - Thiesse, P AU - Thiesse P FAU - Rebillard, A C AU - Rebillard AC FAU - Frappaz, D AU - Frappaz D FAU - Haus, O AU - Haus O FAU - Philip, T AU - Philip T FAU - Favrot, M C AU - Favrot MC LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Int J Cancer JT - International journal of cancer JID - 0042124 SB - IM MH - Biopsy MH - Blotting, Southern MH - Bone Marrow/pathology MH - *Chromosome Aberrations MH - *Chromosomes, Human, Pair 1 MH - Cytogenetics/*methods MH - Fluorescent Antibody Technique MH - Gene Deletion MH - Heterozygote MH - Humans MH - In Situ Hybridization, Fluorescence MH - Interphase MH - Neuroblastoma/*genetics/pathology MH - Polymorphism, Restriction Fragment Length MH - Reproducibility of Results MH - Sensitivity and Specificity MH - Tumor Cells, Cultured EDAT- 1995/04/10 00:00 MHDA- 1995/04/10 00:01 CRDT- 1995/04/10 00:00 PHST- 1995/04/10 00:00 [pubmed] PHST- 1995/04/10 00:01 [medline] PHST- 1995/04/10 00:00 [entrez] AID - 10.1002/ijc.2910610208 [doi] PST - ppublish SO - Int J Cancer. 1995 Apr 10;61(2):185-91. doi: 10.1002/ijc.2910610208.